Diferencia entre revisiones de «Subarachnoid hemorrhage»
(Major update: Ottawa SAH Rule, CT sensitivity by time, Hunt-Hess grade, LP xanthochromia timing, nimodipine for vasospasm, nicardipine for BP, aminocaproic acid, references with PMIDs) |
(Strip excess bold text - keep only critical safety emphasis) |
||
| Línea 1: | Línea 1: | ||
==Background== | ==Background== | ||
*Bleeding into the subarachnoid space (between arachnoid and pia mater) | *Bleeding into the subarachnoid space (between arachnoid and pia mater) | ||
* | *Ruptured cerebral aneurysm accounts for ~85% of nontraumatic SAH | ||
**Most common locations: anterior communicating artery (30%), posterior communicating artery (25%), MCA bifurcation (20%) | **Most common locations: anterior communicating artery (30%), posterior communicating artery (25%), MCA bifurcation (20%) | ||
*Other causes: arteriovenous malformation, perimesencephalic (benign, ~10%), vasculitis, coagulopathy, drug use | *Other causes: arteriovenous malformation, perimesencephalic (benign, ~10%), vasculitis, coagulopathy, drug use | ||
* | *Mortality: ~50% overall (25% die before reaching hospital, 25% die within 30 days) | ||
*Risk factors: | *Risk factors: | ||
**[[Hypertension]] (most important modifiable risk factor) | **[[Hypertension]] (most important modifiable risk factor) | ||
**Smoking, heavy alcohol use | **Smoking, heavy alcohol use | ||
** | **Family history of SAH or aneurysm (first-degree relative) | ||
** | **Polycystic kidney disease, Ehlers-Danlos, connective tissue disorders | ||
**Prior SAH (risk of rebleeding) | **Prior SAH (risk of rebleeding) | ||
**Sympathomimetic drug use ([[cocaine]], [[amphetamines]]) | **Sympathomimetic drug use ([[cocaine]], [[amphetamines]]) | ||
| Línea 15: | Línea 15: | ||
==Clinical Features== | ==Clinical Features== | ||
* | *"Worst headache of my life" — sudden onset, maximal at onset (thunderclap headache) | ||
*'''Sentinel headache''': warning leak days-weeks before major rupture (present in ~30-50%) | *'''Sentinel headache''': warning leak days-weeks before major rupture (present in ~30-50%) | ||
* | *Meningismus (neck stiffness, photophobia) — may take 6-12 hours to develop | ||
* | *Loss of consciousness at onset (~50%) | ||
*Nausea, vomiting (common) | *Nausea, vomiting (common) | ||
* | *Focal neurologic deficits (CN III palsy → posterior communicating artery aneurysm) | ||
* | *Seizures (~10% at onset) | ||
* | *Terson syndrome: intraocular hemorrhage (subhyaloid/vitreous) associated with severe SAH | ||
*'''May present as syncope, cardiac arrest, or altered mental status without headache''' | *'''May present as syncope, cardiac arrest, or altered mental status without headache''' | ||
| Línea 46: | Línea 46: | ||
==Evaluation== | ==Evaluation== | ||
===Non-Contrast CT Head=== | ===Non-Contrast CT Head=== | ||
* | *First-line test | ||
* | *Sensitivity ~98% within 6 hours of onset, ~93% at 12 hours, decreasing to ~50% by day 5-7<ref>Perry JJ, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage. ''BMJ''. 2011;343:d4277. PMID 21768192</ref> | ||
*Fisher grade: amount of blood predicts vasospasm risk | *Fisher grade: amount of blood predicts vasospasm risk | ||
* | *Modern thin-cut CT with experienced radiologist within 6 hours may approach 100% sensitivity | ||
===Lumbar Puncture=== | ===Lumbar Puncture=== | ||
* | *Required if CT negative and clinical suspicion remains | ||
* | *Classic finding: xanthochromia (yellow discoloration from bilirubin in CSF) | ||
**Takes | **Takes 6-12 hours to develop — LP performed <6 hours after onset may miss xanthochromia | ||
*'''Elevated RBCs that do NOT clear''' across sequential tubes (vs traumatic tap which clears) | *'''Elevated RBCs that do NOT clear''' across sequential tubes (vs traumatic tap which clears) | ||
* | *Elevated opening pressure | ||
*Traumatic tap vs SAH: controversial; visual xanthochromia and clinical context are most important | *Traumatic tap vs SAH: controversial; visual xanthochromia and clinical context are most important | ||
===Ottawa SAH Rule=== | ===Ottawa SAH Rule=== | ||
*For alert patients >15 years with new severe nontraumatic headache reaching maximum intensity within 1 hour | *For alert patients >15 years with new severe nontraumatic headache reaching maximum intensity within 1 hour | ||
* | *100% sensitivity (validation study) — if none present, SAH effectively ruled out<ref>Perry JJ, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. ''JAMA''. 2013;310(12):1248-1255. PMID 24065011</ref>: | ||
**Age ≥40 | **Age ≥40 | ||
**Neck pain or stiffness | **Neck pain or stiffness | ||
| Línea 70: | Línea 70: | ||
===CT Angiography (CTA)=== | ===CT Angiography (CTA)=== | ||
* | *Obtain with initial CT if SAH confirmed or high suspicion | ||
*Identifies aneurysm location and morphology for surgical/endovascular planning | *Identifies aneurysm location and morphology for surgical/endovascular planning | ||
*Sensitivity >95% for aneurysms >3 mm | *Sensitivity >95% for aneurysms >3 mm | ||
| Línea 82: | Línea 82: | ||
==Management== | ==Management== | ||
===ED Management=== | ===ED Management=== | ||
* | *ABCs, IV access, continuous monitoring | ||
* | *Blood pressure control: | ||
** | **Target SBP <160 mmHg until aneurysm secured (reduce rebleeding risk) | ||
** | **Nicardipine infusion (5-15 mg/hr, titrate q5min) — preferred | ||
**Labetalol 10-20 mg IV q10-20min | **Labetalol 10-20 mg IV q10-20min | ||
** | **Avoid nitroprusside (increases ICP) | ||
* | *Seizure management: benzodiazepines acutely; prophylactic AEDs controversial | ||
* | *Treat headache: acetaminophen; short-acting opioids cautiously | ||
** | **Avoid ketorolac (platelet inhibition) | ||
* | *Aminocaproic acid (tranexamic acid): may reduce rebleeding risk before aneurysm secured — 4g IV loading dose (discuss with neurosurgery) | ||
* | *Reverse anticoagulation if applicable | ||
===Definitive Treatment=== | ===Definitive Treatment=== | ||
* | *Neurosurgery/neurointerventional consultation emergently | ||
* | *Aneurysm securing (within 24 hours ideally): | ||
** | **Endovascular coiling (preferred for most aneurysms) OR | ||
** | **Surgical clipping | ||
* | *ICU admission | ||
===Complications (Post-Hemorrhage)=== | ===Complications (Post-Hemorrhage)=== | ||
*'''Rebleeding''': highest risk in first 24 hours (~4%); '''most devastating complication''' | *'''Rebleeding''': highest risk in first 24 hours (~4%); '''most devastating complication''' | ||
* | *Vasospasm: occurs days 3-14 (peak day 7); monitor with daily TCDs | ||
**Treat with | **Treat with nimodipine 60 mg PO/NG q4h x 21 days (improves outcomes; does not prevent vasospasm) | ||
**Triple-H therapy (hypertension, hypervolemia, hemodilution) — | **Triple-H therapy (hypertension, hypervolemia, hemodilution) — only after aneurysm secured | ||
* | *Hydrocephalus: acute (requires EVD) or chronic (VP shunt) | ||
* | *Hyponatremia: cerebral salt wasting vs SIADH | ||
* | *Neurogenic cardiac dysfunction: Takotsubo-like, neurogenic pulmonary edema | ||
==Disposition== | ==Disposition== | ||
* | *All confirmed SAH: emergent neurosurgical consultation and ICU admission | ||
* | *Transfer to neurosurgical center if local capabilities unavailable | ||
* | *SAH ruled out (negative CT + negative LP): may discharge with headache precautions and PCP follow-up | ||
==See Also== | ==See Also== | ||
Revisión del 09:22 22 mar 2026
Background
- Bleeding into the subarachnoid space (between arachnoid and pia mater)
- Ruptured cerebral aneurysm accounts for ~85% of nontraumatic SAH
- Most common locations: anterior communicating artery (30%), posterior communicating artery (25%), MCA bifurcation (20%)
- Other causes: arteriovenous malformation, perimesencephalic (benign, ~10%), vasculitis, coagulopathy, drug use
- Mortality: ~50% overall (25% die before reaching hospital, 25% die within 30 days)
- Risk factors:
- Hypertension (most important modifiable risk factor)
- Smoking, heavy alcohol use
- Family history of SAH or aneurysm (first-degree relative)
- Polycystic kidney disease, Ehlers-Danlos, connective tissue disorders
- Prior SAH (risk of rebleeding)
- Sympathomimetic drug use (cocaine, amphetamines)
- Peak incidence: age 40-60; female predominance (1.6:1)
Clinical Features
- "Worst headache of my life" — sudden onset, maximal at onset (thunderclap headache)
- Sentinel headache: warning leak days-weeks before major rupture (present in ~30-50%)
- Meningismus (neck stiffness, photophobia) — may take 6-12 hours to develop
- Loss of consciousness at onset (~50%)
- Nausea, vomiting (common)
- Focal neurologic deficits (CN III palsy → posterior communicating artery aneurysm)
- Seizures (~10% at onset)
- Terson syndrome: intraocular hemorrhage (subhyaloid/vitreous) associated with severe SAH
- May present as syncope, cardiac arrest, or altered mental status without headache
Hunt-Hess Grading
- Grade I: asymptomatic or mild headache
- Grade II: moderate-severe headache, nuchal rigidity, CN palsy
- Grade III: drowsiness, confusion, mild focal deficit
- Grade IV: stupor, moderate-severe hemiparesis
- Grade V: coma, decerebrate posturing
Differential Diagnosis
- Primary headache (migraine, tension, cluster)
- Meningitis / encephalitis
- Intracerebral hemorrhage
- Cerebral venous sinus thrombosis
- Hypertensive emergency
- Reversible cerebral vasoconstriction syndrome (RCVS)
- Cervical artery dissection
- Pituitary apoplexy
Headache
Common
Killers
- Meningitis/encephalitis
- Myocardial ischemia
- Retropharyngeal abscess
- Intracranial Hemorrhage (ICH)
- SAH / sentinel bleed
- Acute obstructive hydrocephalus
- Space occupying lesions
- CVA
- Carbon monoxide poisoning
- Basilar artery dissection
- Preeclampsia
- Cerebral venous thrombosis
- Hypertensive emergency
- Depression
Maimers
- Giant cell arteritis of temporal artery (temporal arteritis)
- Idiopathic intracranial hypertension (Pseudotumor Cerebri)
- Acute Glaucoma
- Acute sinusitis
- Cavernous sinus thrombosis or cerebral sinus thrombosis
- Carotid artery dissection
Others
- Mild traumatic brain injury
- Trigeminal neuralgia
- TMJ pain
- Post-lumbar puncture headache
- Dehydration
- Analgesia abuse
- Various ocular and dental problems
- Herpes zoster ophthalmicus
- Herpes zoster oticus
- Cryptococcosis
- Febrile headache (e.g. pyelonephritis, nonspecific viral infection)
- Ophthalmoplegic migraine
- Superior Vena Cava Syndrome
Aseptic Meningitis
- Viral
- Tuberculosis
- Lyme disease
- Syphilis
- Leptospirosis
- Fungal (AIDS, transplant, chemotherapy, chronic steroid use)
- Noninfectious
Evaluation
Non-Contrast CT Head
- First-line test
- Sensitivity ~98% within 6 hours of onset, ~93% at 12 hours, decreasing to ~50% by day 5-7[1]
- Fisher grade: amount of blood predicts vasospasm risk
- Modern thin-cut CT with experienced radiologist within 6 hours may approach 100% sensitivity
Lumbar Puncture
- Required if CT negative and clinical suspicion remains
- Classic finding: xanthochromia (yellow discoloration from bilirubin in CSF)
- Takes 6-12 hours to develop — LP performed <6 hours after onset may miss xanthochromia
- Elevated RBCs that do NOT clear across sequential tubes (vs traumatic tap which clears)
- Elevated opening pressure
- Traumatic tap vs SAH: controversial; visual xanthochromia and clinical context are most important
Ottawa SAH Rule
- For alert patients >15 years with new severe nontraumatic headache reaching maximum intensity within 1 hour
- 100% sensitivity (validation study) — if none present, SAH effectively ruled out[2]:
- Age ≥40
- Neck pain or stiffness
- Witnessed loss of consciousness
- Onset during exertion
- Thunderclap headache (instant peak)
- Limited neck flexion on exam
CT Angiography (CTA)
- Obtain with initial CT if SAH confirmed or high suspicion
- Identifies aneurysm location and morphology for surgical/endovascular planning
- Sensitivity >95% for aneurysms >3 mm
Labs
- CBC, BMP, coagulation studies (PT/INR, PTT)
- Type and screen
- Troponin (neurogenic myocardial stunning)
- Finger stick glucose
Management
ED Management
- ABCs, IV access, continuous monitoring
- Blood pressure control:
- Target SBP <160 mmHg until aneurysm secured (reduce rebleeding risk)
- Nicardipine infusion (5-15 mg/hr, titrate q5min) — preferred
- Labetalol 10-20 mg IV q10-20min
- Avoid nitroprusside (increases ICP)
- Seizure management: benzodiazepines acutely; prophylactic AEDs controversial
- Treat headache: acetaminophen; short-acting opioids cautiously
- Avoid ketorolac (platelet inhibition)
- Aminocaproic acid (tranexamic acid): may reduce rebleeding risk before aneurysm secured — 4g IV loading dose (discuss with neurosurgery)
- Reverse anticoagulation if applicable
Definitive Treatment
- Neurosurgery/neurointerventional consultation emergently
- Aneurysm securing (within 24 hours ideally):
- Endovascular coiling (preferred for most aneurysms) OR
- Surgical clipping
- ICU admission
Complications (Post-Hemorrhage)
- Rebleeding: highest risk in first 24 hours (~4%); most devastating complication
- Vasospasm: occurs days 3-14 (peak day 7); monitor with daily TCDs
- Treat with nimodipine 60 mg PO/NG q4h x 21 days (improves outcomes; does not prevent vasospasm)
- Triple-H therapy (hypertension, hypervolemia, hemodilution) — only after aneurysm secured
- Hydrocephalus: acute (requires EVD) or chronic (VP shunt)
- Hyponatremia: cerebral salt wasting vs SIADH
- Neurogenic cardiac dysfunction: Takotsubo-like, neurogenic pulmonary edema
Disposition
- All confirmed SAH: emergent neurosurgical consultation and ICU admission
- Transfer to neurosurgical center if local capabilities unavailable
- SAH ruled out (negative CT + negative LP): may discharge with headache precautions and PCP follow-up
See Also
- Intracerebral hemorrhage
- Subdural hemorrhage
- Epidural hemorrhage
- Headache
- Thunderclap headache
- Lumbar puncture
References
- ↑ Perry JJ, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage. BMJ. 2011;343:d4277. PMID 21768192
- ↑ Perry JJ, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA. 2013;310(12):1248-1255. PMID 24065011
- Connolly ES Jr, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline from the AHA/ASA. Stroke. 2012;43(6):1711-1737. PMID 22556195
- Edlow JA, et al. Diagnosis of subarachnoid hemorrhage. Stroke. 2023;54(4):1058-1072. PMID 36848423
- van Gijn J, et al. Subarachnoid haemorrhage. Lancet. 2007;369(9558):306-318. PMID 17258671
